메뉴 건너뛰기




Volumn 9, Issue 1, 2015, Pages

Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling

Author keywords

Bayesian statistical modeling; Breast cancer; Drug resisance; EGFR signaling; Lapatinib; p1 model; Signaling cross talk

Indexed keywords

ERINACEIDAE;

EID: 84927770082     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/s12918-014-0135-x     Document Type: Article
Times cited : (18)

References (68)
  • 1
    • 84896735708 scopus 로고    scopus 로고
    • Signaling cross-talk in the resistance to HER family receptor targeted therapy
    • 23542173
    • Yamaguchi H, Chang SS, Hsu JL, Hung MC. Signaling cross-talk in the resistance to HER family receptor targeted therapy. Oncogene 2014, 33(9):1073-81. 10.1038/onc.2013.74, 23542173.
    • (2014) Oncogene , vol.33 , Issue.9 , pp. 1073-1081
    • Yamaguchi, H.1    Chang, S.S.2    Hsu, J.L.3    Hung, M.C.4
  • 2
    • 84859355565 scopus 로고    scopus 로고
    • Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
    • 22474259
    • Logue JS, Morrison DK. Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev 2012, 26(7):641-50. 10.1101/gad.186965.112, 22474259.
    • (2012) Genes Dev , vol.26 , Issue.7 , pp. 641-650
    • Logue, J.S.1    Morrison, D.K.2
  • 3
    • 69949151386 scopus 로고    scopus 로고
    • Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
    • 19629074
    • Jänne PA, Gray N, Settleman J. Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. Nat Rev Drug Discov 2009, 8(9):709-23. 10.1038/nrd2871, 19629074.
    • (2009) Nat Rev Drug Discov , vol.8 , Issue.9 , pp. 709-723
    • Jänne, P.A.1    Gray, N.2    Settleman, J.3
  • 4
    • 0028232828 scopus 로고
    • Expression of cytokeratin confers multiple drug resistance
    • 7515497
    • Bauman PA, Dalton WS, Anderson JM, Cress AE. Expression of cytokeratin confers multiple drug resistance. Proc Nat Acad Sci USA 1994, 91(12):5311-4. 10.1073/pnas.91.12.5311, 7515497.
    • (1994) Proc Nat Acad Sci USA , vol.91 , Issue.12 , pp. 5311-5314
    • Bauman, P.A.1    Dalton, W.S.2    Anderson, J.M.3    Cress, A.E.4
  • 6
    • 84864402225 scopus 로고    scopus 로고
    • Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
    • 22751098
    • Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, et al. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet 2012, 44(8):852-60. 10.1038/ng.2330, 22751098.
    • (2012) Nat Genet , vol.44 , Issue.8 , pp. 852-860
    • Zhang, Z.1    Lee, J.C.2    Lin, L.3    Olivas, V.4    Au, V.5    LaFramboise, T.6
  • 7
    • 84871998076 scopus 로고    scopus 로고
    • An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance
    • 23091115
    • Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 2013, 19:279-90. 10.1158/1078-0432.CCR-12-1558, 23091115.
    • (2013) Clin Cancer Res , vol.19 , pp. 279-290
    • Byers, L.A.1    Diao, L.2    Wang, J.3    Saintigny, P.4    Girard, L.5    Peyton, M.6
  • 8
    • 84867760241 scopus 로고    scopus 로고
    • HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation
    • 22956644
    • Takezawa K, Pirazzoli V, Arcila ME, Nebhan CA, Song X, et al. HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation. Cancer Discov 2012, 2(10):922-33. 10.1158/2159-8290.CD-12-0108, 22956644.
    • (2012) Cancer Discov , vol.2 , Issue.10 , pp. 922-933
    • Takezawa, K.1    Pirazzoli, V.2    Arcila, M.E.3    Nebhan, C.A.4    Song, X.5
  • 9
    • 34249075147 scopus 로고    scopus 로고
    • MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
    • 17463250
    • Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007, 316(5827):1039-43. 10.1126/science.1141478, 17463250.
    • (2007) Science , vol.316 , Issue.5827 , pp. 1039-1043
    • Engelman, J.A.1    Zejnullahu, K.2    Mitsudomi, T.3    Song, Y.4    Hyland, C.5    Park, J.O.6
  • 10
    • 75149129568 scopus 로고    scopus 로고
    • Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy
    • 20028874
    • Zhuang G, Brantley-Sieders DM, Vaught D, Yu J, Xie L, Wells S, et al. Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy. Cancer Res 2010, 70:299-308. 10.1158/0008-5472.CAN-09-1845, 20028874.
    • (2010) Cancer Res , vol.70 , pp. 299-308
    • Zhuang, G.1    Brantley-Sieders, D.M.2    Vaught, D.3    Yu, J.4    Xie, L.5    Wells, S.6
  • 11
    • 79958026380 scopus 로고    scopus 로고
    • The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
    • 21531565
    • Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 2011, 36(6):320-8. 10.1016/j.tibs.2011.03.006, 21531565.
    • (2011) Trends Biochem Sci , vol.36 , Issue.6 , pp. 320-328
    • Mendoza, M.C.1    Er, E.E.2    Blenis, J.3
  • 12
    • 34948845576 scopus 로고    scopus 로고
    • Lapatinib in the treatment of breast cancer
    • 17892419
    • Higa GM, Abraham J. Lapatinib in the treatment of breast cancer. Expert Rev Anticancer Ther 2007, 7(9):1183-92. 10.1586/14737140.7.9.1183, 17892419.
    • (2007) Expert Rev Anticancer Ther , vol.7 , Issue.9 , pp. 1183-1192
    • Higa, G.M.1    Abraham, J.2
  • 13
    • 51549083821 scopus 로고    scopus 로고
    • Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases
    • 18803986
    • Medina PJ, Goodin S. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases. Clin Ther 2008, 30(8):1426-47. 10.1016/j.clinthera.2008.08.008, 18803986.
    • (2008) Clin Ther , vol.30 , Issue.8 , pp. 1426-1447
    • Medina, P.J.1    Goodin, S.2
  • 14
    • 79953207364 scopus 로고    scopus 로고
    • Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
    • 21385943
    • Garrett JT, Olivares MG, Rinehart C, Granja-Ingram ND, Sanchez V, Chakrabarty A, et al. Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. Proc Nat Acad Sci USA 2011, 108(12):5021-6. 10.1073/pnas.1016140108, 21385943.
    • (2011) Proc Nat Acad Sci USA , vol.108 , Issue.12 , pp. 5021-5026
    • Garrett, J.T.1    Olivares, M.G.2    Rinehart, C.3    Granja-Ingram, N.D.4    Sanchez, V.5    Chakrabarty, A.6
  • 15
    • 79953162369 scopus 로고    scopus 로고
    • Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure
    • 21377448
    • Azuma K, Tsurutani J, Sakai K, Kaneda H, Fujisaka Y, Takeda M, et al. Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure. Biochem Biophys Res Commun 2011, 407:219-24. 10.1016/j.bbrc.2011.03.002, 21377448.
    • (2011) Biochem Biophys Res Commun , vol.407 , pp. 219-224
    • Azuma, K.1    Tsurutani, J.2    Sakai, K.3    Kaneda, H.4    Fujisaka, Y.5    Takeda, M.6
  • 16
    • 70149109569 scopus 로고    scopus 로고
    • Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL
    • 19671800
    • Liu L, Greger J, Shi H, Liu Y, Greshock J, Annan R, et al. Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res 2009, 69(17):6871-8. 10.1158/0008-5472.CAN-08-4490, 19671800.
    • (2009) Cancer Res , vol.69 , Issue.17 , pp. 6871-6878
    • Liu, L.1    Greger, J.2    Shi, H.3    Liu, Y.4    Greshock, J.5    Annan, R.6
  • 17
    • 84864200812 scopus 로고    scopus 로고
    • The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells.
    • Komurov K, Tseng JT, Muller M, Seviour EG, Moss TJ, Yang L, et al. The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells. Mol Syst Biol. 2012; 8(1)..
    • (2012) Mol Syst Biol. , vol.8 , Issue.1
    • Komurov, K.1    Tseng, J.T.2    Muller, M.3    Seviour, E.G.4    Moss, T.J.5    Yang, L.6
  • 18
    • 26844487041 scopus 로고    scopus 로고
    • Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor
    • 16037379
    • Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor. Endocrinology 2005, 146(11):4609-18. 10.1210/en.2005-0247, 16037379.
    • (2005) Endocrinology , vol.146 , Issue.11 , pp. 4609-4618
    • Knowlden, J.M.1    Hutcheson, I.R.2    Barrow, D.3    Gee, J.M.4    Nicholson, R.I.5
  • 19
    • 77649166990 scopus 로고    scopus 로고
    • Bayesian statistical modelling of human protein interaction network incorporating protein disorder information
    • 20100321
    • Bulashevska S, Bulashevska A, Eils R. Bayesian statistical modelling of human protein interaction network incorporating protein disorder information. BMC Bioinformatics 2010, 11:46. 10.1186/1471-2105-11-46, 20100321.
    • (2010) BMC Bioinformatics , vol.11 , pp. 46
    • Bulashevska, S.1    Bulashevska, A.2    Eils, R.3
  • 20
    • 84868020742 scopus 로고    scopus 로고
    • Bayesian inference of signaling network topology in a cancer cell line
    • 22923301
    • Hill SM, Lu Y, Molina J, Heiser LM, Spellman PT, Speed TP, et al. Bayesian inference of signaling network topology in a cancer cell line. Bioinformatics 2012, 28(21):2804-10. 10.1093/bioinformatics/bts514, 22923301.
    • (2012) Bioinformatics , vol.28 , Issue.21 , pp. 2804-2810
    • Hill, S.M.1    Lu, Y.2    Molina, J.3    Heiser, L.M.4    Spellman, P.T.5    Speed, T.P.6
  • 21
    • 84860851412 scopus 로고    scopus 로고
    • Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks
    • 22579283
    • Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, MacBeath G, et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012, 149(4):780-94. 10.1016/j.cell.2012.03.031, 22579283.
    • (2012) Cell , vol.149 , Issue.4 , pp. 780-794
    • Lee, M.J.1    Ye, A.S.2    Gardino, A.K.3    Heijink, A.M.4    Sorger, P.K.5    MacBeath, G.6
  • 22
    • 33847285870 scopus 로고    scopus 로고
    • Oncogenic re-wiring of cellular signaling pathways
    • 17322911
    • Pawson T, Warner N. Oncogenic re-wiring of cellular signaling pathways. Oncogene 2007, 26(9):1268-75. 10.1038/sj.onc.1210255, 17322911.
    • (2007) Oncogene , vol.26 , Issue.9 , pp. 1268-1275
    • Pawson, T.1    Warner, N.2
  • 24
    • 84950607156 scopus 로고
    • An exponential family of probability distributions for directed graphs
    • Holland PW, Leinhardt S. An exponential family of probability distributions for directed graphs. J Am Stat Assoc 1981, 76(373):33-50. 10.1080/01621459.1981.10477598.
    • (1981) J Am Stat Assoc , vol.76 , Issue.373 , pp. 33-50
    • Holland, P.W.1    Leinhardt, S.2
  • 25
    • 0011376709 scopus 로고
    • A proposed index of the conformity of one sociometric measurement to another
    • Katz L, Powell J. A proposed index of the conformity of one sociometric measurement to another. Psychometrika 1953, 18(3):249-56. 10.1007/BF02289063.
    • (1953) Psychometrika , vol.18 , Issue.3 , pp. 249-256
    • Katz, L.1    Powell, J.2
  • 26
    • 0030491229 scopus 로고    scopus 로고
    • Logit models and logistic regressions for social networks: I. An introduction to Markov graphs andp
    • Wasserman S, Pattison P. Logit models and logistic regressions for social networks: I. An introduction to Markov graphs andp. Psychometrika 1996, 61(3):401-25. 10.1007/BF02294547.
    • (1996) Psychometrika , vol.61 , Issue.3 , pp. 401-425
    • Wasserman, S.1    Pattison, P.2
  • 27
    • 0001399123 scopus 로고
    • Pseudolikelihood estimation for social networks
    • Strauss D, Ikeda M. Pseudolikelihood estimation for social networks. J Am Stat Assoc 1990, 85(409):204-12. 10.1080/01621459.1990.10475327.
    • (1990) J Am Stat Assoc , vol.85 , Issue.409 , pp. 204-212
    • Strauss, D.1    Ikeda, M.2
  • 28
    • 0003314308 scopus 로고    scopus 로고
    • Markov chain monte carlo estimation of exponential random graph models.
    • Snijders TAB. Markov chain monte carlo estimation of exponential random graph models. J Soc Struct. 2002; 3(2)..
    • (2002) J Soc Struct. , vol.3 , Issue.2
    • Snijders, T.A.B.1
  • 29
    • 0006407254 scopus 로고    scopus 로고
    • WinBUGS - A Bayesian modelling framework: concepts, structure, and extensibility
    • Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - A Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000, 10(4):325-37. [http://dx.doi.org/10.1023/A:1008929526011]., 10.1023/A:1008929526011.
    • (2000) Stat Comput , vol.10 , Issue.4 , pp. 325-337
    • Lunn, D.J.1    Thomas, A.2    Best, N.3    Spiegelhalter, D.4
  • 31
    • 45449101889 scopus 로고    scopus 로고
    • A global pathway crosstalk network
    • 18434343
    • Li Y, Agarwal P, Rajagopalan D. A global pathway crosstalk network. Bioinformatics 2008, 24(12):1442-7. 10.1093/bioinformatics/btn200, 18434343.
    • (2008) Bioinformatics , vol.24 , Issue.12 , pp. 1442-1447
    • Li, Y.1    Agarwal, P.2    Rajagopalan, D.3
  • 33
    • 0037805576 scopus 로고    scopus 로고
    • The KEGG database
    • 12539951
    • Kanehisa M. The KEGG database. Novartis Found Symp 2002, 247:91-101. 10.1002/0470857897.ch8, 12539951.
    • (2002) Novartis Found Symp , vol.247 , pp. 91-101
    • Kanehisa, M.1
  • 35
    • 84862203775 scopus 로고    scopus 로고
    • WikiPathways: building research communities on biological pathways
    • 22096230
    • Kelder T, van Iersel MP, Hanspers K, Kutmon M, Conklin BR, et al. WikiPathways: building research communities on biological pathways. Nucleic Acids Res 2012, 40(Database issue):D1301-7. 10.1093/nar/gkr1074, 22096230.
    • (2012) Nucleic Acids Res , vol.40 , Issue.Database issue , pp. D1301-D1307
    • Kelder, T.1    van Iersel, M.P.2    Hanspers, K.3    Kutmon, M.4    Conklin, B.R.5
  • 36
    • 84862630475 scopus 로고    scopus 로고
    • NetWalker: a contextual network analysis tool for functional genomics
    • 22732065
    • Komurov K, Dursun S, Erdin S, Ram P. NetWalker: a contextual network analysis tool for functional genomics. BMC Genomics 2012, 13:282. 10.1186/1471-2164-13-282, 22732065.
    • (2012) BMC Genomics , vol.13 , pp. 282
    • Komurov, K.1    Dursun, S.2    Erdin, S.3    Ram, P.4
  • 37
    • 84880306937 scopus 로고    scopus 로고
    • The Notch signaling pathway as a mediator of tumor survival
    • 23585460
    • Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 2013, 34(7):1420-30. 10.1093/carcin/bgt127, 23585460.
    • (2013) Carcinogenesis , vol.34 , Issue.7 , pp. 1420-1430
    • Capaccione, K.M.1    Pine, S.R.2
  • 38
    • 33646257783 scopus 로고    scopus 로고
    • Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression
    • 16618740
    • Liu ZJ, Xiao M, Balint K, Smalley KS, Brafford P, Qiu R, et al. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res 2006, 66(8):4182-90. 10.1158/0008-5472.CAN-05-3589, 16618740.
    • (2006) Cancer Res , vol.66 , Issue.8 , pp. 4182-4190
    • Liu, Z.J.1    Xiao, M.2    Balint, K.3    Smalley, K.S.4    Brafford, P.5    Qiu, R.6
  • 39
    • 0029085935 scopus 로고
    • Signalling downstream of activated mammalian Notch
    • 7566092
    • Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature 1995, 377(6547):355-8. 10.1038/377355a0, 7566092.
    • (1995) Nature , vol.377 , Issue.6547 , pp. 355-358
    • Jarriault, S.1    Brou, C.2    Logeat, F.3    Schroeter, E.H.4    Kopan, R.5    Israel, A.6
  • 40
    • 34948908663 scopus 로고    scopus 로고
    • Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
    • 17873882
    • Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007, 13(10):1203-10. 10.1038/nm1636, 17873882.
    • (2007) Nat Med , vol.13 , Issue.10 , pp. 1203-1210
    • Palomero, T.1    Sulis, M.L.2    Cortina, M.3    Real, P.J.4    Barnes, K.5    Ciofani, M.6
  • 41
    • 33845306813 scopus 로고    scopus 로고
    • NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth
    • 17114293
    • Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Nat Acad Sci USA 2006, 103(48):18261-6. 10.1073/pnas.0606108103, 17114293.
    • (2006) Proc Nat Acad Sci USA , vol.103 , Issue.48 , pp. 18261-18266
    • Palomero, T.1    Lim, W.K.2    Odom, D.T.3    Sulis, M.L.4    Real, P.J.5    Margolin, A.6
  • 42
    • 33746546368 scopus 로고    scopus 로고
    • C-Myc is an important direct target of Notch1 in T-cell lymphoblastic leukemia/lymphoma
    • 16847353
    • Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, et al. c-Myc is an important direct target of Notch1 in T-cell lymphoblastic leukemia/lymphoma. Genes Dev 2006, 20(15):2096-109. 10.1101/gad.1450406, 16847353.
    • (2006) Genes Dev , vol.20 , Issue.15 , pp. 2096-2109
    • Weng, A.P.1    Millholland, J.M.2    Yashiro-Ohtani, Y.3    Arcangeli, M.L.4    Lau, A.5    Wai, C.6
  • 43
    • 0343517577 scopus 로고    scopus 로고
    • Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2
    • 10644343
    • Strobl LJ, Hofelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol 2000, 74(4):1727-35. 10.1128/JVI.74.4.1727-1735.2000, 10644343.
    • (2000) J Virol , vol.74 , Issue.4 , pp. 1727-1735
    • Strobl, L.J.1    Hofelmayr, H.2    Marschall, G.3    Brielmeier, M.4    Bornkamm, G.W.5    Zimber-Strobl, U.6
  • 44
    • 0035736487 scopus 로고    scopus 로고
    • HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
    • 11715018
    • Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001, 3(11):973-82. 10.1038/ncb1101-973, 11715018.
    • (2001) Nat Cell Biol , vol.3 , Issue.11 , pp. 973-982
    • Zhou, B.P.1    Liao, Y.2    Xia, W.3    Zou, Y.4    Spohn, B.5    Hung, M.C.6
  • 45
    • 17844379782 scopus 로고    scopus 로고
    • TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells
    • 15735750
    • Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, Affabris E, et al. TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells. Oncogene 2005, 24(15):2536-46. 10.1038/sj.onc.1208403, 15735750.
    • (2005) Oncogene , vol.24 , Issue.15 , pp. 2536-2546
    • Vannucchi, S.1    Chiantore, M.V.2    Fiorucci, G.3    Percario, Z.A.4    Leone, S.5    Affabris, E.6
  • 46
    • 22244486994 scopus 로고    scopus 로고
    • The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53
    • 16023600
    • Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Nagao T, et al. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 2005, 8:75-87. 10.1016/j.ccr.2005.06.006, 16023600.
    • (2005) Cancer Cell , vol.8 , pp. 75-87
    • Higashitsuji, H.1    Higashitsuji, H.2    Itoh, K.3    Sakurai, T.4    Nagao, T.5
  • 47
    • 84860491093 scopus 로고    scopus 로고
    • Role of Wnt/beta-catenin signaling in drug resistance of pancreatic cancer
    • 22372504
    • Cui J, Jiang W, Wang S, Wang L, Xie K. Role of Wnt/beta-catenin signaling in drug resistance of pancreatic cancer. Curr Pharm Des 2012, 18(17):2464-71. 10.2174/13816128112092464, 22372504.
    • (2012) Curr Pharm Des , vol.18 , Issue.17 , pp. 2464-2471
    • Cui, J.1    Jiang, W.2    Wang, S.3    Wang, L.4    Xie, K.5
  • 48
    • 19944403876 scopus 로고    scopus 로고
    • Wnt/β-catenin signaling pathway as a novel cancer drug target
    • 15578921
    • Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, et al. Wnt/β-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004, 4(8):653-71. 10.2174/1568009043332709, 15578921.
    • (2004) Curr Cancer Drug Targets , vol.4 , Issue.8 , pp. 653-671
    • Luu, H.H.1    Zhang, R.2    Haydon, R.C.3    Rayburn, E.4    Kang, Q.5    Si, W.6
  • 49
    • 84875505291 scopus 로고    scopus 로고
    • The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
    • 23547709
    • Loh YN, Hedditch EL, Baker LA, Jary E, Ward RL, Ford CE. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. BMC Cancer 2013, 13:174. 10.1186/1471-2407-13-174, 23547709.
    • (2013) BMC Cancer , vol.13 , pp. 174
    • Loh, Y.N.1    Hedditch, E.L.2    Baker, L.A.3    Jary, E.4    Ward, R.L.5    Ford, C.E.6
  • 50
    • 77955078486 scopus 로고    scopus 로고
    • Inhibition of Wnt signaling pathway decreases chemotherapyresistant side-population colon cancer cells
    • 20651349
    • Chikazawa N, Tanaka H, Tasaka T, Nakamura M, Tanaka M, et al. Inhibition of Wnt signaling pathway decreases chemotherapyresistant side-population colon cancer cells. Anticancer Res 2010, 30(6):2041-8. 20651349.
    • (2010) Anticancer Res , vol.30 , Issue.6 , pp. 2041-2048
    • Chikazawa, N.1    Tanaka, H.2    Tasaka, T.3    Nakamura, M.4    Tanaka, M.5
  • 51
    • 84863384604 scopus 로고    scopus 로고
    • NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma
    • 22439932
    • Yamaguchi T, Yanagisawa K, Sugiyama R, Hosono Y, Shimada Y, Arima C, et al. NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell 2012, 21(3):348-61. 10.1016/j.ccr.2012.02.008, 22439932.
    • (2012) Cancer Cell , vol.21 , Issue.3 , pp. 348-361
    • Yamaguchi, T.1    Yanagisawa, K.2    Sugiyama, R.3    Hosono, Y.4    Shimada, Y.5    Arima, C.6
  • 52
    • 75349109588 scopus 로고    scopus 로고
    • Nuclear APC
    • 19928349
    • Neufeld KL. Nuclear APC. Adv Exp Med Biol 2009, 656:13-29. 10.1007/978-1-4419-1145-2_2, 19928349.
    • (2009) Adv Exp Med Biol , vol.656 , pp. 13-29
    • Neufeld, K.L.1
  • 53
  • 54
    • 0023841872 scopus 로고
    • Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line
    • 3349449
    • Kraker AJ, Moore CW. Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line. Cancer Lett 1988, 38(3):307-14. 10.1016/0304-3835(88)90022-5, 3349449.
    • (1988) Cancer Lett , vol.38 , Issue.3 , pp. 307-314
    • Kraker, A.J.1    Moore, C.W.2
  • 55
    • 84871846692 scopus 로고    scopus 로고
    • WNT signalling pathways as therapeutic targets in cancer
    • Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2012, 13:11-26. [http://dx.doi.org/10.1038/nrc3419]., 10.1038/nrc3419.
    • (2012) Nat Rev Cancer , vol.13 , pp. 11-26
    • Anastas, J.N.1    Moon, R.T.2
  • 56
    • 84862013453 scopus 로고    scopus 로고
    • β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
    • 22610277
    • Tenbaum SP, Ordonez-Moran P, Puig I, Chicote I, Arques O, Landolfi S, et al. β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 2012, 18(6):892-901. 10.1038/nm.2772, 22610277.
    • (2012) Nat Med , vol.18 , Issue.6 , pp. 892-901
    • Tenbaum, S.P.1    Ordonez-Moran, P.2    Puig, I.3    Chicote, I.4    Arques, O.5    Landolfi, S.6
  • 57
    • 84892171530 scopus 로고    scopus 로고
    • GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli
    • 24393163
    • Zhan X, Wang J, Liu Y, Peng Y, Tan W. GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli. Mol Cancer 2014, 13:4. 10.1186/1476-4598-13-4, 24393163.
    • (2014) Mol Cancer , vol.13 , pp. 4
    • Zhan, X.1    Wang, J.2    Liu, Y.3    Peng, Y.4    Tan, W.5
  • 59
    • 42449109533 scopus 로고    scopus 로고
    • Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2
    • 18359851
    • Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, Okamoto K, et al. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc Nat Acad Sci USA 2008, 105(12):4838-43. 10.1073/pnas.0712216105, 18359851.
    • (2008) Proc Nat Acad Sci USA , vol.105 , Issue.12 , pp. 4838-4843
    • Abe, Y.1    Oda-Sato, E.2    Tobiume, K.3    Kawauchi, K.4    Taya, Y.5    Okamoto, K.6
  • 60
    • 77952546990 scopus 로고    scopus 로고
    • Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling
    • 20207148
    • Ayers KL, Therond PP. Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling. Trends Cell Biol 2010, 20(5):287-98. 10.1016/j.tcb.2010.02.002, 20207148.
    • (2010) Trends Cell Biol , vol.20 , Issue.5 , pp. 287-298
    • Ayers, K.L.1    Therond, P.P.2
  • 61
    • 59349106501 scopus 로고    scopus 로고
    • Hedgehog signaling: is Smo a G protein-coupled receptor?
    • 19211052
    • Philipp M, Caron MG. Hedgehog signaling: is Smo a G protein-coupled receptor?. Curr Biol 2009, 19(3):R125-7. 10.1016/j.cub.2008.12.010, 19211052.
    • (2009) Curr Biol , vol.19 , Issue.3 , pp. R125-R127
    • Philipp, M.1    Caron, M.G.2
  • 62
    • 70349148288 scopus 로고    scopus 로고
    • Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy
    • 19754359
    • van der Veeken J, Oliveira S, Schiffelers RM, Storm G, van Bergen En Henegouwen PM, Roovers RC. Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets 2009, 9(6):748-60. 10.2174/156800909789271495, 19754359.
    • (2009) Curr Cancer Drug Targets , vol.9 , Issue.6 , pp. 748-760
    • van der Veeken, J.1    Oliveira, S.2    Schiffelers, R.M.3    Storm, G.4    Van Bergen En Henegouwen, P.M.5    Roovers, R.C.6
  • 63
    • 84864006046 scopus 로고    scopus 로고
    • Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls
    • 22423264
    • Fidler MJ, Shersher DD, Borgia JA, Bonomi P. Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls. Ther Adv Med Oncol 2012, 4(2):51-60. 10.1177/1758834011427576, 22423264.
    • (2012) Ther Adv Med Oncol , vol.4 , Issue.2 , pp. 51-60
    • Fidler, M.J.1    Shersher, D.D.2    Borgia, J.A.3    Bonomi, P.4
  • 64
    • 84881490675 scopus 로고    scopus 로고
    • Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair
    • 23950876
    • Wang Y, Yuan JL, Zhang YT, Ma JJ, Xu P, Shi CH, et al. Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair. PLoS ONE 2013, 8(8):e68784. 10.1371/journal.pone.0068784, 23950876.
    • (2013) PLoS ONE , vol.8 , Issue.8
    • Wang, Y.1    Yuan, J.L.2    Zhang, Y.T.3    Ma, J.J.4    Xu, P.5    Shi, C.H.6
  • 65
    • 65549158055 scopus 로고    scopus 로고
    • High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
    • 19153117
    • Ludovini V, Bellezza G, Pistola L, Bianconi F, Di Carlo L, Sidoni A, et al. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Ann Oncol 2009, 20(5):842-9. 10.1093/annonc/mdn727, 19153117.
    • (2009) Ann Oncol , vol.20 , Issue.5 , pp. 842-849
    • Ludovini, V.1    Bellezza, G.2    Pistola, L.3    Bianconi, F.4    Di Carlo, L.5    Sidoni, A.6
  • 66
    • 47549108868 scopus 로고    scopus 로고
    • Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance
    • 17902048
    • Knowlden JM, Jones HE, Barrow D, Gee JM, Nicholson RI, Hutcheson IR. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance. Breast Cancer Res Treat 2008, 111:79-91. 10.1007/s10549-007-9763-9, 17902048.
    • (2008) Breast Cancer Res Treat , vol.111 , pp. 79-91
    • Knowlden, J.M.1    Jones, H.E.2    Barrow, D.3    Gee, J.M.4    Nicholson, R.I.5    Hutcheson, I.R.6
  • 67
    • 32044435126 scopus 로고    scopus 로고
    • Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways
    • 16452501
    • Levine AJ, Feng Z, Mak TW, You H, Jin S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 2006, 20(3):267-75. 10.1101/gad.1363206, 16452501.
    • (2006) Genes Dev , vol.20 , Issue.3 , pp. 267-275
    • Levine, A.J.1    Feng, Z.2    Mak, T.W.3    You, H.4    Jin, S.5
  • 68
    • 84881116878 scopus 로고    scopus 로고
    • Voting-based cancer module identification by combining topological and data-driven properties
    • 23940583
    • Azad AK, Lee H. Voting-based cancer module identification by combining topological and data-driven properties. PLoS ONE 2013, 8(8):e70498. 10.1371/journal.pone.0070498, 23940583.
    • (2013) PLoS ONE , vol.8 , Issue.8
    • Azad, A.K.1    Lee, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.